Greater Glasgow and Clyde Medicines

Formulary Search Results for: SODIUM ZIRCONIUM CYCLOSILICATE emergency

If the searched medicine is not listed in the NHSGGC Formulary, please check if the relevant therapeutic chapter is now available on the West of Scotland Formulary — visit formulary.nhs.scot/west.

12.1.3 Removal of ear wax - View Category

Preferred List
SODIUM BICARBONATE

Prescribing Notes:

Ear drops 5%.

BNF Link

7.4.3 Drugs used in urological pain - View Category

Total Formulary
Specialist and GP
SODIUM BICARBONATE

Restrictions:

Restricted to specialist initiation.

BNF Link

9.2.1.3 Oral bicarbonate - View Category

Total Formulary
Specialist and GP
SODIUM BICARBONATE

Restrictions:

Restricted to specialist initiation.

Prescribing Notes:

Please note, expiry dates of licensed and unlicensed oral solutions can vary greatly.

BNF Link

9.2.1.2 Oral sodium and water - View Category

Total Formulary
Specialist and GP
SODIUM BICARBONATE

Restrictions:

Restricted to specialist initiation.

Prescribing Notes:

Please note, expiry dates of licensed and unlicensed oral solutions can vary greatly.

BNF Link

9.2.1.1 Oral potassium - View Category

Total Formulary
Specialist Only
PATIROMER (Veltassa) (oral suspension)

Restrictions:

Restricted to specialist use in the emergency care setting for the treatment of acute, life-threatening hyperkalaemia alongside standard care.

BNF Link

9.2.1.1 Oral potassium - View Category

Total Formulary
Specialist Only
SODIUM POLYSTYRENE SULPHONATE

Restrictions:

Restricted to specialist use only.

BNF Link

16.2 Specific antidotes - View Category

Total Formulary
Specialist Only
SODIUM CALCIUM EDETATE

Restrictions:

Restricted to specialist use only.

BNF Link

16.2 Specific antidotes - View Category

Total Formulary
Specialist Only
SODIUM NITRITE

Restrictions:

Restricted to specialist use only.

BNF Link

6.6.2 Bisphosphonates and other drugs affecting bone metabolism - View Category

Preferred List
RISEDRONATE SODIUM

Prescribing Notes:

Risedronate is the second line bisphosphonate for osteoporosis and should only be used in patients who either fail to tolerate alendronic acid because of gastrointestinal side effects or when alendronic acid is considered inappropriate because of existing active dyspeptic symptoms. Treatment of osteoporosis in men at high risk of fractures remains non-Formulary.

BNF Link

6.6.2 Bisphosphonates and other drugs affecting bone metabolism - View Category

Total Formulary
Specialist and GP
SODIUM CLODRONATE

Restrictions:

Restricted to specialist initiation.

BNF Link